Mechanism study of novel CCR5 antagonists and their potential as anti-HIV-1 microbicides
R5-tropic HIV-1 is predominantly transmitted during unprotected sexual contacts, rendering CCR5 antagonist as an attractive agent not only for antiretroviral therapy but also for prevention. Here, we report two 1,3,3,4-tetrasubstituted pyrrolidine embodied compounds, TD-0232 and TD-0680, as novel s...
Main Authors: | Kang, Yuanxi., 康元曦. |
---|---|
Language: | English |
Published: |
The University of Hong Kong (Pokfulam, Hong Kong)
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/10722/182280 |
Similar Items
-
Chemokines and HIV: The First Close Encounter
by: Paolo eLusso
Published: (2015-06-01) -
CCR5/CXCR4 Dual Antagonism for the Improvement of HIV Infection Therapy
by: Fedora Grande, et al.
Published: (2019-02-01) -
CCR5 genotype and plasma ß-chemokine concentration of Brazilian HIV-infected individuals
by: Mikawa A.Y., et al.
Published: (2002-01-01) -
A Study of CD4, CCR3, CCR4, CCR5, CXCR3 Expression in Peripheral Blood Lymphocytes of Patients with Gastric Cancer
by: Alireza Andalib, et al.
Published: (2012-03-01) -
Use of maraviroc, the first CCR5 receptor antagonist, in HIV treatment regimens
by: A V Kravchenko
Published: (2013-11-01)